| Nerve injury and regeneration | Lifetime | 104 | TW 1 | 99.19 |
| Tryptophan and brain disorders | Lifetime | 144 | TW 1 | 99.09 |
| Autism Spectrum Disorder Research | Lifetime | 156 | TW 1 | 98.95 |
| Attention Deficit Hyperactivity Disorder | Lifetime | 198 | TW 2 | 98.39 |
| Bipolar Disorder and Treatment | Lifetime | 243 | TW 1 | 98.55 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 399 | TW 1 | 98.35 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 364 | TW 1 | 98.03 |
| Receptor Mechanisms and Signaling | Lifetime | 910 | TW 1 | 98.03 |
| Stress Responses and Cortisol | Lifetime | 661 | TW 1 | 97.80 |
| Treatment of Major Depression | Lifetime | 284 | TW 1 | 97.83 |
| Functional Brain Connectivity Studies | Lifetime | 881 | TW 3 | 97.93 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 690 | TW 3 | 96.88 |
| Schizophrenia research and treatment | Lifetime | 729 | TW 2 | 97.74 |
| Nuclear Receptors and Signaling | Lifetime | 242 | TW 2 | 96.48 |
| Adolescent and Pediatric Healthcare | Lifetime | 766 | TW 2 | 94.38 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 807 | TW 3 | 94.58 |
| Suicide and Self-Harm Studies | Lifetime | 987 | TW 6 | 93.62 |
| Pain Management and Treatment | Lifetime | 720 | TW 2 | 89.32 |
| Tryptophan and brain disorders | 2021-2025 | 68 | TW 4 | 97.81 |
| Functional Brain Connectivity Studies | 2021-2025 | 261 | TW 3 | 97.40 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 97 | TW 1 | 95.06 |
| Stress Responses and Cortisol | 2021-2025 | 146 | TW 3 | 94.93 |
| Autism Spectrum Disorder Research | 2021-2025 | 233 | TW 3 | 95.60 |
| Treatment of Major Depression | 2021-2025 | 97 | TW 4 | 95.52 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 271 | TW 2 | 93.99 |
| Bipolar Disorder and Treatment | 2021-2025 | 164 | TW 5 | 94.82 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 198 | TW 6 | 93.93 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 371 | TW 4 | 90.61 |
| Child Nutrition and Feeding Issues | 2021-2025 | 300 | TW 2 | 90.84 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 938 | TW 7 | 87.93 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 502 | TW 18 | 85.49 |
| Pain Management and Treatment | 2021-2025 | 395 | TW 3 | 77.76 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 648 | TW 1 | 78.95 |
| Electroconvulsive Therapy Studies | 2021-2025 | 586 | TW 9 | 63.53 |
| Body Image and Dysmorphia Studies | 2021-2025 | 866 | TW 4 | 55.37 |
